(85 days)
Not Found
No
The summary does not mention AI, ML, or any related terms, and the device description focuses on standard ultrasound imaging modes and hardware.
No
The device is designed for diagnostic purposes, specifically to collect ultrasonic image data for medical diagnosis or examination, not for treating or preventing diseases or conditions.
Yes
The "Intended Use / Indications for Use" section explicitly states that the device is "designed to collect ultrasonic image data of the human body for diagnostic purposes." It further clarifies that it "offers a procedure applied to the human body for medical diagnosis or examination."
No
The device description explicitly states it is a "portable ultrasound system" and mentions hardware components like transducers, a pole cart, a power extension unit, and a foot switch. It also describes the system's ability to transmit and receive ultrasound waves, which requires hardware.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections. They are performed outside of the living organism.
- Device Function: The description clearly states that the Ultrasound System SONIMAGE HS1 uses the ultrasonic pulse-echo method to visualize structures within the human body. It is applied to the human body for medical diagnosis or examination.
- Lack of Sample Analysis: There is no mention of analyzing samples taken from the body. The system directly interacts with the body to generate images.
Therefore, this device falls under the category of medical imaging equipment used for in-vivo (within the living organism) diagnosis, not in-vitro diagnosis.
N/A
Intended Use / Indications for Use
The Ultrasound System SONIMAGE HS1 and its transducers are products designed to collect ultrasonic image data of the human body for diagnostic purposes. The system employs the ultrasonic pulse-echo method to visualize the anatomic structures, characteristics, and dynamics of the human body, and using an image display, Doppler display and/or Doppler sound, offers a procedure applied to the human body for medical diagnosis or examination. The range of intended clinical applications is same as other conventional ultrasound imaging systems for general purpose, such as small parts, abdomen, obstetrics, gynecology, musculoskeletal (soft tissue), peripheral vascular, and Cardiac.
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
Product codes (comma separated list FDA assigned to the subject device)
IYN, IYO, ITX
Device Description
The Ultrasound System SONIMAGE HS1 is a portable ultrasound system for general purposes. The system provides ultrasound imaging information such as used for the purpose of diagnosing the human body, which visually represents the internal geometry, characteristics and dynamics of the human body, and transmits / receives ultrasound waves to obtain image data of the visual representation. This system provides ultrasound images in all its modes of B-mode, M-mode, Color Doppler-mode, PW Doppler-mode, and Elastography-mode.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasonic pulsed doppler imaging system
Anatomical Site
Small parts, abdomen, obstetrics, gynecology, musculoskeletal (soft tissue), peripheral vascular, and Cardiac.
Indicated Patient Age Range
Not Found
Intended User / Care Setting
fully qualified and certified medical personnel.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The geometric accuracy verification in B-mode, position for Elastography-mode, and the accuracy verification of the position and the velocity for Color Doppler-mode, PW/CW Doppler-mode and TDI-mode, and the time for PW/CW Doppler-mode and ECG trace are comprehensively tested as Bench-tests with successful results, except quantitative Doppler sensitivity. The proposed system and the predicate systems do not have a quantitative claims of sensitivity regarding Color Doppler-mode, TDI-mode and PW/CW Doppler-mode. All of the verification activities, as required by the risk analysis, for the proposed system was performed and the results demonstrated that the predetermined acceptance criteria were met.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1550 Ultrasonic pulsed doppler imaging system.
(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
Image /page/0/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is a stylized image of three human profiles facing to the right, stacked on top of each other.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
October 19, 2016
KONICA MINOLTA, INC. % Mr. Russell D. Munves Official Correspondent Storch Amini & Munves PC 140 east 45th Street, 25th Floor NEW YORK NY 10017
Re: K162065
Trade/Device Name: Ultrasound System SONIMAGE HS1 Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: II Product Code: IYN, IYO, ITX Dated: July 25, 2016 Received: July 26, 2016
Dear Mr. Munves:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
1
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours.
Michael O'Hara
For
Robert Ochs, Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health
Enclosure
2
DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration
Indications for Use
510(k) Number (if known)
Device Name Ultrasound System SONIMAGE HS1
Indications for Use (Describe)
The Ultrasound System SONIMAGE HS1 and its transducers are products designed to collect ultrasonic image data of the human body for diagnostic purposes. The system employs the ultrasonic pulse-echo method to visualize the anatomic structures, characteristics, and dynamics of the human body, and using an image display, Doppler display and/or Doppler sound, offers a procedure applied to the human body for medical diagnosis or examination. The range of intended clinical applications is same as other conventional ultrasound imaging systems for general purpose, such as small parts, abdomen, obstetrics, gynecology, musculoskeletal (soft tissue), peripheral vascular, and Cardiac.
Type of Use (Select one or both, as applicable)
Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Druq Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below.
3
Ultrasound System SONIMAGE HS1 System:
Transducer:
Clinical Application | Mode of Operation | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track 1 Only) | Specific | |||||||
(Tracks 1 & 3) | B | M | PWD | CWD | Color | |||
Doppler | Combined | |||||||
(Specify) | Other* | |||||||
(Specify) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal | ||||||||
Imaging | ||||||||
& Other | Fetal | N | N | N | N | N | Note1 | Note2 |
Abdominal | P | P | P | P | P | Note1 | Note2,4 | |
Intra-operative (Specify) | ||||||||
Intra-operative (Neuro) | ||||||||
Laparoscopic | ||||||||
Pediatric | ||||||||
Small Organ (Note3) | P | P | P | P | Note1 | Note2, 5 | ||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | ||||||||
Trans-vaginal | N | N | N | N | N | Note1 | Note2 | |
Trans-urethral | ||||||||
Trans-esoph. (non-Card.) | ||||||||
Musculo-skeletal (Conventional) | P | P | P | P | Note1 | Note2, 5 | ||
Musculo-skeletal (Superficial) | P | P | P | P | Note1 | Note2, 5 | ||
Intravascular | ||||||||
Other (Specify) | ||||||||
Cardiac | Cardiac Adult | P | P | P | P | P | Note1 | Note2,4 |
Cardiac Pediatric | P | P | P | P | P | Note1 | Note2,4 | |
Intravascular (Cardiac) | ||||||||
Trans-esoph. (Cardiac) | ||||||||
Intra-cardiac | ||||||||
Other (Specify) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | P | P | P | P | Note1 | Note2, 5 | |
Other (Specify) |
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
N = new indication; P = previously cleared by FDA; E = added under this appendix
Note 1: Combined mode BM (B + M), BD (B + Pulse Doppler), BcMc (Color Doppler + M Color Doppler) and BcD (B Color Doppler + Pulse Doppler)
Note 2: Other mode Mc (M Color Mode)
Note 3: Small organ includes thyroid and breast
Note 4: Other mode CF-TDI(Color Flow - Tissue Doppler Imaging) and PW-TDI(Pulse Doppler - Tissue Doppler Imaging)
Note 5: Other mode Elastography
4
Clinical Application | Mode of Operation | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track 1 Only) | Specific | |||||||
(Tracks 1 & 3) | B | M | PWD | CWD | Color | |||
Doppler | Combined | |||||||
(Specify) | Other* | |||||||
(Specify) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal | ||||||||
Imaging | ||||||||
& Other | Fetal | |||||||
Abdominal | ||||||||
Intra-operative (Specify) | ||||||||
Intra-operative (Neuro) | ||||||||
Laparoscopic | ||||||||
Pediatric | ||||||||
Small Organ (Note3) | P | P | P | P | Note1 | Note2, 4 | ||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esoph. (non-Card.) | ||||||||
Musculo-skeletal (Conventional) | P | P | P | P | Note1 | Note2, 4 | ||
Musculo-skeletal (Superficial) | P | P | P | P | Note1 | Note2, 4 | ||
Intravascular | ||||||||
Other (Specify) | ||||||||
Cardiac | Cardiac Adult | |||||||
Cardiac Pediatric | ||||||||
Intravascular (Cardiac) | ||||||||
Trans-esoph. (Cardiac) | ||||||||
Intra-cardiac | ||||||||
Other (Specify) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | P | P | P | P | Note1 | Note2, 4 | |
Other (Specify) |
N = new indication; P = previously cleared by FDA; E = added under this appendix
Note 1: Combined mode BM (B + M), BD (B + Pulse Doppler), BcMc (Color Doppler + M Color Doppler) and BcD (B Color Doppler + Pulse Doppler)
Note 2: Other mode Mc (M Color Mode)
Note 3: Small organ includes thyroid and breast
Note 4: Other mode Elastography
5
Ultrasound System SONIMAGE HS1 System: Transducer: C5-2
Clinical Application | Mode of Operation | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
General | ||||||||||
(Track 1 Only) | Specific | |||||||||
(Tracks 1 & 3) | B | M | PWD | CWD | Color | |||||
Doppler | Combined | |||||||||
(Specify) | Other* | |||||||||
(Specify) | ||||||||||
Ophthalmic | Ophthalmic | |||||||||
Fetal | ||||||||||
Imaging | ||||||||||
& Other | Fetal | N | N | N | N | Note1 | Note2 | |||
Abdominal | P | P | P | P | Note1 | Note2 | ||||
Intra-operative (Specify) | ||||||||||
Intra-operative (Neuro) | ||||||||||
Laparoscopic | ||||||||||
Pediatric | ||||||||||
Small Organ (Specify) | ||||||||||
Neonatal Cephalic | ||||||||||
Adult Cephalic | ||||||||||
Trans-rectal | ||||||||||
Trans-vaginal | ||||||||||
Trans-urethral | ||||||||||
Trans-esoph. (non-Card.) | ||||||||||
Musculo-skeletal (Conventional) | ||||||||||
Musculo-skeletal (Superficial) | ||||||||||
Intravascular | ||||||||||
Other (Specify) | ||||||||||
Cardiac | Cardiac Adult | |||||||||
Cardiac Pediatric | ||||||||||
Intravascular (Cardiac) | ||||||||||
Trans-esoph. (Cardiac) | ||||||||||
Intra-cardiac | ||||||||||
Other (Specify) | ||||||||||
Peripheral | Peripheral vessel | |||||||||
Vessel | Other (Specify) |
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
N = new indication; P = previously cleared by FDA; E = added under this appendix
Note 1: Combined mode BM (B + M), BD (B + Pulse Doppler), BcMc (Color Doppler + M Color Doppler) and BcD (B Color Doppler + Pulse Doppler)
Note 2: Other mode Mc (M Color Mode)
6
Ultrasound System SONIMAGE HS1 System: Transducer: S4-2
Clinical Application | Mode of Operation | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
General | ||||||||||
(Track 1 Only) | Specific | |||||||||
(Tracks 1 & 3) | B | M | PWD | CWD | Color | |||||
Doppler | Combined | |||||||||
(Specify) | Other* | |||||||||
(Specify) | ||||||||||
Ophthalmic | Ophthalmic | |||||||||
Fetal | Fetal | |||||||||
Imaging | Abdominal | P | P | P | P | P | Note1 | Note2,3 | ||
& Other | Intra-operative (Specify) | |||||||||
Intra-operative (Neuro) | ||||||||||
Laparoscopic | ||||||||||
Pediatric | ||||||||||
Small Organ (Specify) | ||||||||||
Neonatal Cephalic | ||||||||||
Adult Cephalic | ||||||||||
Trans-rectal | ||||||||||
Trans-vaginal | ||||||||||
Trans-urethral | ||||||||||
Trans-esoph. (non-Card.) | ||||||||||
Musculo-skeletal (Conventional) | ||||||||||
Musculo-skeletal (Superficial) | ||||||||||
Intravascular | ||||||||||
Other (Specify) | ||||||||||
Cardiac | Cardiac Adult | P | P | P | P | P | Note1 | Note2,3 | ||
Cardiac Pediatric | P | P | P | P | P | Note1 | Note2,3 | |||
Intravascular (Cardiac) | ||||||||||
Trans-esoph. (Cardiac) | ||||||||||
Intra-cardiac | ||||||||||
Other (Specify) | ||||||||||
Peripheral | Peripheral vessel | |||||||||
Vessel | Other (Specify) |
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
N = new indication; P = previously cleared by FDA; E = added under this appendix
Note 1: Combined mode BM (B + M), BD (B + Pulse Doppler), BcMc (Color Doppler + M Color Doppler) and BcD (B Color Doppler + Pulse Doppler)
Note 2: Other mode Mc (M Color Mode)
Note 3: Other mode CF-TDI(Color Flow - Tissue Doppler Imaging) and PW-TDI(Pulse Doppler - Tissue Doppler Imaging)
7
Ultrasound System SONIMAGE HS1 System: Transducer: L14-4
Clinical Application | Mode of Operation | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track 1 Only) | Specific | |||||||
(Tracks 1 & 3) | B | M | PWD | CWD | Color | |||
Doppler | Combined | |||||||
(Specify) | Other* | |||||||
(Specify) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal | ||||||||
Imaging | ||||||||
& Other | Fetal | |||||||
Abdominal | ||||||||
Intra-operative (Specify) | ||||||||
Intra-operative (Neuro) | ||||||||
Laparoscopic | ||||||||
Pediatric | ||||||||
Small Organ (Note3) | P | P | P | P | Note1 | Note2 | ||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esoph. (non-Card.) | ||||||||
Musculo-skeletal (Conventional) | P | P | P | P | Note1 | Note2 | ||
Musculo-skeletal (Superficial) | P | P | P | P | Note1 | Note2 | ||
Intravascular | ||||||||
Other (Specify) | ||||||||
Cardiac | Cardiac Adult | |||||||
Cardiac Pediatric | ||||||||
Intravascular (Cardiac) | ||||||||
Trans-esoph. (Cardiac) | ||||||||
Intra-cardiac | ||||||||
Other (Specify) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | P | P | P | P | Note1 | Note2 | |
Other (Specify) |
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
N = new indication; P = previously cleared by FDA; E = added under this appendix
Note 1: Combined mode BM (B + M), BD (B + Pulse Doppler), BcMc (Color Doppler + M Color Doppler) and BcD (B Color Doppler + Pulse Doppler)
Note 2: Other mode Mc (M Color Mode)
Note 3: Small organ includes thyroid and breast
8
Ultrasound System SONIMAGE HS1 System: Transducer: EC9-3
Clinical Application | Mode of Operation | ||||||||
---|---|---|---|---|---|---|---|---|---|
General | |||||||||
(Track 1 Only) | Specific | ||||||||
(Tracks 1 & 3) | B | M | PWD | CWD | Color | ||||
Doppler | Combined | ||||||||
(Specify) | Other* | ||||||||
(Specify) | |||||||||
Ophthalmic | Ophthalmic | ||||||||
Fetal | Fetal | N | N | N | N | Note1 | Note2 | ||
Imaging | Abdominal | ||||||||
& Other | Intra-operative (Specify) | ||||||||
Intra-operative (Neuro) | |||||||||
Laparoscopic | |||||||||
Pediatric | |||||||||
Small Organ (Specify) | |||||||||
Neonatal Cephalic | |||||||||
Adult Cephalic | |||||||||
Trans-rectal | |||||||||
Trans-vaginal | N | N | N | N | Note1 | Note2 | |||
Trans-urethral | |||||||||
Trans-esoph. (non-Card.) | |||||||||
Musculo-skeletal (Conventional) | |||||||||
Musculo-skeletal (Superficial) | |||||||||
Intravascular | |||||||||
Other (Specify) | |||||||||
Cardiac | Cardiac Adult | ||||||||
Cardiac Pediatric | |||||||||
Intravascular (Cardiac) | |||||||||
Trans-esoph. (Cardiac) | |||||||||
Intra-cardiac | |||||||||
Other (Specify) | |||||||||
Peripheral | Peripheral vessel | ||||||||
Vessel | Other (Specify) |
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
N = new indication; P = previously cleared by FDA; E = added under this appendix
Note 1: Combined mode BM (B + M), BD (B + Pulse Doppler), BcMc (Color Doppler + M Color Doppler) and BcD (B Color Doppler + Pulse Doppler)
Note 2: Other mode Mc (M Color Mode)
9
Ultrasound System SONIMAGE HS1 System: Transducer: L11-3
Clinical Application | Mode of Operation | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track 1 Only) | Specific | |||||||
(Tracks 1 & 3) | B | M | PWD | CWD | Color | |||
Doppler | Combined | |||||||
(Specify) | Other* | |||||||
(Specify) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal | ||||||||
Imaging | ||||||||
& Other | Fetal | |||||||
Abdominal | ||||||||
Intra-operative (Specify) | ||||||||
Intra-operative (Neuro) | ||||||||
Laparoscopic | ||||||||
Pediatric | ||||||||
Small Organ (Note3) | N | N | N | N | Note1 | Note2, 4 | ||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esoph. (non-Card.) | ||||||||
Musculo-skeletal (Conventional) | N | N | N | N | Note1 | Note2, 4 | ||
Musculo-skeletal (Superficial) | N | N | N | N | Note1 | Note2, 4 | ||
Intravascular | ||||||||
Other (Specify) | ||||||||
Cardiac | Cardiac Adult | |||||||
Cardiac Pediatric | ||||||||
Intravascular (Cardiac) | ||||||||
Trans-esoph. (Cardiac) | ||||||||
Intra-cardiac | ||||||||
Other (Specify) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | N | N | N | N | Note1 | Note2, 4 | |
Other (Specify) |
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
N = new indication; P = previously cleared by FDA; E = added under this appendix
Note 1: Combined mode BM (B + M), BD (B + Pulse Doppler), BcMc (Color Doppler + M Color Doppler) and BcD (B Color Doppler + Pulse Doppler)
Note 2: Other mode Mc (M Color Mode)
Note 3: Small organ includes thyroid and breast
Note 4: Other mode Elastography
10
Ultrasound System SONIMAGE HS1 System: Transducer: MC10-3
Clinical Application | Mode of Operation | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track 1 Only) | Specific | |||||||
(Tracks 1 & 3) | B | M | PWD | CWD | Color | |||
Doppler | Combined | |||||||
(Specify) | Other* | |||||||
(Specify) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Imaging | ||||||||
& Other | Fetal | |||||||
Abdominal | ||||||||
Intra-operative (Specify) | ||||||||
Intra-operative (Neuro) | ||||||||
Laparoscopic | ||||||||
Pediatric | ||||||||
Small Organ (Note3) | N | N | N | N | Note1 | Note2 | ||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esoph. (non-Card.) | ||||||||
Musculo-skeletal (Conventional) | N | N | N | N | Note1 | Note2 | ||
Musculo-skeletal (Superficial) | N | N | N | N | Note1 | Note2 | ||
Intravascular | ||||||||
Other (Specify) | ||||||||
Cardiac | Cardiac Adult | |||||||
Cardiac Pediatric | ||||||||
Intravascular (Cardiac) | ||||||||
Trans-esoph. (Cardiac) | ||||||||
Intra-cardiac | ||||||||
Other (Specify) | ||||||||
Peripheral | Peripheral vessel | N | N | N | N | Note1 | Note2 | |
Vessel | Other (Specify) |
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
N = new indication; P = previously cleared by FDA; E = added under this appendix
Note 1: Combined mode BM (B + M), BD (B + Pulse Doppler), BcMc (Color Doppler + M Color Doppler) and BcD (B Color Doppler + Pulse Doppler)
Note 2: Other mode Mc (M Color Mode)
Note 3: Small organ includes thyroid and breast
11
Ultrasound System SONIMAGE HS1 System: Transducer: HL18-4
Clinical Application | Mode of Operation | |||||||
---|---|---|---|---|---|---|---|---|
General | ||||||||
(Track 1 Only) | Specific | |||||||
(Tracks 1 & 3) | B | M | PWD | CWD | Color | |||
Doppler | Combined | |||||||
(Specify) | Other* | |||||||
(Specify) | ||||||||
Ophthalmic | Ophthalmic | |||||||
Fetal | ||||||||
Imaging | ||||||||
& Other | Fetal | |||||||
Abdominal | ||||||||
Intra-operative (Specify) | ||||||||
Intra-operative (Neuro) | ||||||||
Laparoscopic | ||||||||
Pediatric | ||||||||
Small Organ (Note3) | N | N | N | N | Note1 | Note2 | ||
Neonatal Cephalic | ||||||||
Adult Cephalic | ||||||||
Trans-rectal | ||||||||
Trans-vaginal | ||||||||
Trans-urethral | ||||||||
Trans-esoph. (non-Card.) | ||||||||
Musculo-skeletal (Conventional) | N | N | N | N | Note1 | Note2 | ||
Musculo-skeletal (Superficial) | N | N | N | N | Note1 | Note2 | ||
Intravascular | ||||||||
Other (Specify) | ||||||||
Cardiac | Cardiac Adult | |||||||
Cardiac Pediatric | ||||||||
Intravascular (Cardiac) | ||||||||
Trans-esoph. (Cardiac) | ||||||||
Intra-cardiac | ||||||||
Other (Specify) | ||||||||
Peripheral | ||||||||
Vessel | Peripheral vessel | |||||||
Other (Specify) |
Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows:
N = new indication; P = previously cleared by FDA; E = added under this appendix
Note 1: Combined mode BM (B + M), BD (B + Pulse Doppler), BcMc (Color Doppler + M Color Doppler) and BcD (B Color Doppler + Pulse Doppler)
Note 2: Other mode Mc (M Color Mode)
Note 3: Small organ includes thyroid and breast
12
510(k) Summary
Submitter's Name: | KONICA MINOLTA, INC. |
---|---|
Address: | 1 Sakura-machi, |
Hino-shi, 191-8511 Japan | |
Contact: | Tsutomu Fukui |
Telephone: | +81 42 589 8429 |
Date: | July 25, 2016 |
Trade Name: | Ultrasound System SONIMAGE HS1 |
Model No: | SONIMAGE HS1 |
Common Name: | Ultrasound Imaging System |
Classification Name(s): | Ultrasonic Pulsed Doppler Imaging System (21 CFR 892.1550) |
Ultrasonic Pulsed Echo Imaging System (21 CFR 892.1560) | |
Diagnostic Ultrasound Transducer (21 CFR 892.1570) | |
Classification Number(s): | 90-IYN; 90-IYO; 90-ITX |
Regulatory Class: | Class II |
Predicate Device(s): | K152577 - Ultrasound System SONIMAGE HS1, Konica Minolta, Inc. |
K061605 - Nemio XG, SSA-580A, Toshiba America Medical Systems, Inc. | |
K142368 - Noblus Ultrasound Diagnostic System, Hitachi Aloka Medical, | |
Ltd. | |
Device Description: | The Ultrasound System SONIMAGE HS1 is a portable ultrasound system |
for general purposes. The system provides ultrasound imaging | |
information such as used for the purpose of diagnosing the human body, | |
which visually represents the internal geometry, characteristics and | |
dynamics of the human body, and transmits / receives ultrasound waves | |
to obtain image data of the visual representation. | |
This system provides ultrasound images in all its modes of B-mode, M- | |
mode, Color Doppler-mode, PW Doppler-mode, and Elastography-mode. |
13
It is also capable with Anatomical M-mode, CW Doppler-mode and CF/PW-TDI-mode with Sector transducer.
The optional items are available, such as a Pole Cart with storage basket, a power extension unit, and a foot switch with dual/triple pedals.
The system can be connected to LAN through the wired Ethernet and, is also capable of wireless LAN with the OTS USB-WiFi adapter supporting security of WPA/WPA2 and WEP.
This system conforms to Real Time Display of Thermal and Mechanical Output Indices on Diagnostic Ultrasound Equipment (Track 3). Transducers have their own characteristic applications, and are brought into contact with the body surface.
The Ultrasound System SONIMAGE HS1 and its transducers are designed to comply with the following standards:
AAMI / ANSI ES 60601-1: 2005 and A1: 2012, C1:2009 and A2:2010; IEC 60601-1-6: 2010; IEC 60601-1-2: 2007; IEC 60601-2-37: 2007; IEC 62304: 2006; ISO 10993-1:2009; NEMA UD 2-2004; NEMA UD 3-2004;
Intended Use:
The Ultrasound System SONIMAGE HS1 and its transducers are products designed to collect ultrasonic image data of the human body for diagnostic purposes.
The system employs the ultrasonic pulse-echo method to visualize the anatomic structures, characteristics, and dynamics of the human body, and using an image display, Doppler display and/or Doppler sound, offers a procedure applied to the human body for medical diagnosis or examination.
The range of intended clinical applications is same as the predicate device, such as small parts, abdomen, obstetrics, gynecology, musculoskeletal (soft tissue), peripheral vascular, and cardiac.
This system is contraindicated for an eyeball examination or any other examination that may require the passage of an ultrasound beam
14
through an eyeball. This system is NOT designed for use in direct contact to central nerves and cardiac systems.
The system should not be used by persons other than fully qualified and certified medical personnel.
Summary of Technological Characteristics
Compared to Predicate Device:
The proposed Ultrasound System SONIMAGE HS1 employs the same fundamental scientific technologies as the primary predicate device (K152577). For the functions other than K152577's, the other predicates are referenced such as the Nemio XG SSA-580A system (K061605) and the Noblus Ultrasound Diagnostic System (K142368). The summary of comparisons of technological characteristics for the proposed device and the predicate systems are provided as follows;
Intended Use
The intended use for the proposed device is essentially the same as the conventional ultrasound diagnostic system for general purpose. The additional clinical applications to the primary predicate device, obstetrics and gynecology, are the same indication for use as other predicate device (K061605).
Operating Principle and designing
The system transmits ultrasonic energy into patients, then perform post processing of received echoes to generate on-screen display of anatomic structures, characteristics, and dynamics of the human body. The system is designed in laptop shape to be transportable with battery operation. These operating principle and designing are the same as the predicate devices.
The proposed system provide Elastography-mode utilized by same Strain Elastography techniques as the predicate device (K142368). The both systems require to move the ultrasound transducer manually by the operator to provide the information of elasticity of interested tissue as superimposed color image on B-mode image on the display.
The enhancements of measurement and report functions by the software modification from the primary predicate device do not introduce new features other than the traditional items for the conventional diagnostic ultrasound systems.
15
The proposed new transducers are a conventional diagnostic ultrasound transducers. All of them employs the same fundamental scientific technologies as the predicate devices.
The proposed system and the predicate devices support the same operating modes and display format, the same measurement functions for anatomic structures, internal geometry, characteristics and dynamics of the human body.
Non-clinical test
The geometric accuracy verification in B-mode, position for Elastographymode, and the accuracy verification of the position and the velocity for Color Doppler-mode, PW/CW Doppler-mode and TDI-mode, and the time for PW/CW Doppler-mode and ECG trace are comprehensively tested as Bench-tests with successful results, except quantitative Doppler sensitivity. The proposed system and the predicate systems do not have a quantitative claims of sensitivity regarding Color Doppler-mode, TDImode and PW/CW Doppler-mode.
All of the verification activities, as required by the risk analysis, for the proposed system was performed and the results demonstrated that the predetermined acceptance criteria were met.
Safety
The system is in conformance with the standards described above, which are same standards to those of the primary predicate device (K152577). The both systems conform to real time display of thermal and mechanical output indices under Track 3.
Biocompatibility
The all patient contact materials of human body surface are evaluated under ISO 10993 and determined as acceptable for these usage. The proposed system and the predicate systems achieve same acceptance level for biocompatibility.
Conclusion:
The clinical studies are not required to support substantial equivalence for these conventional ultrasound diagnostic equipment. In addition to that, as discussed in the above technological comparison, the technological characteristics of the Ultrasound System SONIMAGE HS1 are deemed to be substantially equivalent to the aforementioned predicate devices that have already been cleared for USA distribution with 510(k) premarket notification.